Medical News

RSS

LA/hypnosis combination during surgery can aid healing process, reduce drug use and hospital stay time

Using a combination of hypnosis and local anaesthesia (LA) for certain types of surgery can aid the healing process and reduce drug use and time spent in hospital, anaesthesiologists have found. The combination could also help avoid cancer recurrence and metastases, according to new research to be presented today at the European Anaesthesiology Congress in Amsterdam.

13 Jun 2011

Noninvasive ventilation can shorten intubation time and may reduce risk of post-extubation ARF

Noninvasive ventilation (NIV) used as a weaning technique for mechanically ventilated patients can shorten intubation time and may reduce the risk of post-extubation acute respiratory failure (ARF), according to French researchers.

13 Jun 2011

Governments need to address disability to achieve MDGs, WHO/World Bank report says

More than one billion people worldwide live with a physical or mental disability, with 80 percent of those people living in developing countries, according to the first world report on disability, published by the WHO and World Bank on Thursday, the Guardian reports.

13 Jun 2011

IASLC releases interactive staging tool in thoracic oncology

The International Association for the Study of Lung Cancer (IASLC), the only global organization dedicated to the study of lung cancer, today announced the release of its Staging Atlas in Thoracic Oncology as a downloadable application for iPad, iPhone, Android or BlackBerry.

13 Jun 2011

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Incyte Corporation announced today additional symptom improvement and quality of life (QoL) results from COMFORT-I, a randomized, double-blinded, placebo-controlled Phase III trial of Incyte's JAK1 and JAK2 inhibitor, ruxolitinib, in patients with myelofibrosis (MF).

13 Jun 2011

Scientists pioneer way to find more chromosomal aberrations in tumors

Washington University Pediatric Cancer Genome Project scientists pioneer way to find more chromosomal aberrations in tumors; results likely to advance understanding of cancer.

13 Jun 2011

Kurma, CRT launch BliNK Therapeutics to generate monoclonal antibodies

Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.

13 Jun 2011

The U.S. and the GAVI Alliance

This fact sheet from the Kaiser Family Foundation examines the GAVI Alliance and the role the U.S. government plays in supporting the partnership. Created in 1999, GAVI began operations in January 2000 and by the end of 2010 had received over $5 billion in donor financing and disbursed over $2.8 billion to support immunization programs in 76 low- and middle-income countries.

13 Jun 2011

Seattle Genetics, Millennium ADCETRIS phase I trial data on Hodgkin lymphoma presented at EHA

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc., announced today that data on ADCETRIS (brentuximab vedotin) in relapsed or refractory Hodgkin lymphoma patients were featured in an oral presentation at the 16th Congress of the European Hematology Association (EHA) in London.

13 Jun 2011

Only 35% of anaesthesiologists carry out cardiac output monitoring during high-risk surgery

Only 35% of anaesthesiologists are carrying out a simple procedure during high-risk surgery that can make a significant impact on how well patients recover from their operations, according to new research presented today at the European Anaesthesiology Congress in Amsterdam.

13 Jun 2011

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Alexion Pharmaceuticals, Inc. today announced the presentation of final data from the two Phase 2 studies of Soliris as a treatment for patients with atypical hemolytic uremic syndrome.

13 Jun 2011

Merck receives FDA approval for redesigned drug container labels

The U.S. Food and Drug Administration today is announcing the approval of Merck's redesigned drug container labels that include a new standardized format to improve readability and provide better information on product and strength differentiation.

13 Jun 2011

Pawlenty rips Romney's health plan; other GOP candidates get ready to rumble

In advance of Monday night's GOP presidential contenders' debate, news outlets covered candidates ramping up the rhetoric on health care.

13 Jun 2011

Siemens receives FDA clearance for Biograph mMR system to perform simultaneous PET/MRI scan

The U.S. Food and Drug Administration today cleared the Siemens Biograph mMR system, the first device to simultaneously perform a positron emission tomography scan, commonly known as PET scan, and a magnetic resonance imaging (MRI) scan.

From Siemens Healthineers 13 Jun 2011

The U.S. commitment to GAVI

In a post on the Center for Global Development's "Global Health Policy" blog, Amanda Glassman, CGD's director of global health policy, discusses the U.S. pledge for the GAVI Alliance and outlines why providing $450 million over three years to GAVI "is both compassionate and cost-effective".

13 Jun 2011

Cell division linked to oxygen levels: Johns Hopkins research

Cells grow abundant when oxygen is available, and generally stop when it is scarce. Although this seems straightforward, no direct link ever has been established between the cellular machinery that senses oxygen and that which controls cell division. Now, in the June 10 issue of Molecular Cell, researchers at Johns Hopkins report that the MCM proteins, which promote cell division, also directly control the oxygen-sensing HIF-1 protein.

12 Jun 2011

Preliminary results from Edison's EPI-A0001 28-day phase 2A trial against Friedreich's ataxia

Edison Pharmaceuticals, Inc. announced today preliminary results obtained on a 28-day phase 2A clinical trial in Friedreich's ataxia. While the primary endpoint of glucose disposition index did not show statistically significant improvement, EPI-A0001 did significantly improve neurological function as assessed by the Friedreich's Ataxia Rating Scale.

10 Jun 2011

Researchers unearth secret of immune system's success

After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success. The findings published online on June 9th in Immunity, a Cell Press publication, offer an explanation for how specialized immune cells are able to kill infected or cancerous cells without killing themselves in the process.

From Evident Corporation - Life Sciences 10 Jun 2011

New opportunities to save another 6.4 million lives

Vaccinating children around the world against infectious diseases has saved the lives of millions over the past several decades. Now new opportunities exist to overcome remaining challenges-and save another 6.4 million lives over the current decade, according articles in the June 2011 edition of Health Affairs. The issue was produced under the journal's grant from the Bill & Melinda Gates Foundation.

10 Jun 2011

Legislation that slows human embryonic stem cell research will also harm iPS cells study

Any legislation that slows human embryonic stem cell research is likely to also seriously harm the study of induced pluripotent stem cells, according to a new study by researchers at the Stanford University School of Medicine, the Mayo Clinic and the University of Michigan.

10 Jun 2011

Medical News

LA/hypnosis combination during surgery can aid healing process, reduce drug use and hospital stay time

Noninvasive ventilation can shorten intubation time and may reduce risk of post-extubation ARF

Governments need to address disability to achieve MDGs, WHO/World Bank report says

IASLC releases interactive staging tool in thoracic oncology

Incyte announces additional results from ruxolitinib Phase III trial on myelofibrosis

Scientists pioneer way to find more chromosomal aberrations in tumors

Kurma, CRT launch BliNK Therapeutics to generate monoclonal antibodies

The U.S. and the GAVI Alliance

Seattle Genetics, Millennium ADCETRIS phase I trial data on Hodgkin lymphoma presented at EHA

Only 35% of anaesthesiologists carry out cardiac output monitoring during high-risk surgery

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Merck receives FDA approval for redesigned drug container labels

Pawlenty rips Romney's health plan; other GOP candidates get ready to rumble

Siemens receives FDA clearance for Biograph mMR system to perform simultaneous PET/MRI scan

The U.S. commitment to GAVI

Cell division linked to oxygen levels: Johns Hopkins research

Preliminary results from Edison's EPI-A0001 28-day phase 2A trial against Friedreich's ataxia

Researchers unearth secret of immune system's success

New opportunities to save another 6.4 million lives

Legislation that slows human embryonic stem cell research will also harm iPS cells study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News